新治疗药物通过触发细胞内ROS风暴来诱导癌细胞快速死亡
Yongbin Liu1, Dongfang Yu1, Xueying Ge2
1Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA.
Biomaterials
|September 14, 2024
概括
一种新的以为基础的药物,载体,有效地诱导癌细胞中的活性氧物种 (ROS),导致细胞快速死亡. 这种新型药物克服了当前治疗方法的局限性,并显示出对抗多药耐药性癌症的承诺,毒性最小.
科学领域:
- 生物化学 生物化学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 活性氧物种 (ROS) 生产对于癌症治疗至关重要,但由于ROS产生不足,目前的诱导剂的有效性有限.
- 基于的药物在化疗中被广泛使用,主要通过DNA间隔作用来诱导亡.
研究的目的:
- 设计和评估一种基于 (Pt) 的新型药物,载体,通过ROS诱导增强癌症治疗.
- 研究载体的作用机制和抗瘤功效,特别是针对多药耐药性癌症.
主要方法:
- 开发载体,一种药物,将基于Pt的超微小纳米颗粒集成到聚氨基酸载体中.
- 对ROS产生的评估,癌细胞死亡模式,以及体外和体内抗瘤功效.
- 将载体的机制与传统的基于Pt的药物进行比较,重点关注DNA损伤和细胞死亡途径.
主要成果:
- 运载极大地触发了癌细胞中ROS的爆发,在30分钟内导致细胞死亡.
- 携带引发了一种独特的细胞死亡模式,与细胞亡或铁亡不同,独立于DNA损伤.
- 已证明对广泛的癌症,包括多抗药类型的抗瘤疗效优异,具有最小的全身毒性.
结论:
- 载体白金代表了一种新型的抗癌疗法,其独特的作用机制基于强大的ROS催化活性.
- 药物诱导癌细胞快速死亡和克服多药物耐药性的能力突显了其治疗潜力.
- 这些发现揭示了在除了DNA损伤之外的癌症细胞根除中的新作用,为创新的化疗策略铺平了道路.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
01:46Electron Transport Chain: Complex I and II
12.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K